Trial · NCT02282813
Adverse events264
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 264
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | CTAP101 Capsules (Not Randomized; 6 Mos Treatment) | 7 | 103 | 7 |
| other | Anaemia | Blood and lymphatic system disorders | CTAP101 Capsules (Not Randomized; 12 Mos Treatment) | 9 | 153 | 9 |
| other | Anaemia | Blood and lymphatic system disorders | CTAP101 Caps 2 x 30 mcg Daily for 12 wk+Adjunctive | 2 | 42 | 2 |
| other | Constipation | Gastrointestinal disorders | CTAP101 Capsules (Not Randomized; 6 Mos Treatment) | 7 | 103 | 7 |
| other | Constipation | Gastrointestinal disorders | CTAP101 Capsules (Not Randomized; 12 Mos Treatment) | 6 | 153 | 6 |
| other | Constipation | Gastrointestinal disorders | CTAP101 Caps 2 x 30 mcg Daily for 12 wk+Adjunctive | 0 | 42 | 0 |
| other | Diarrhoea | Gastrointestinal disorders | CTAP101 Capsules (Not Randomized; 6 Mos Treatment) | 7 | 103 | 7 |
| other | Diarrhoea | Gastrointestinal disorders | CTAP101 Capsules (Not Randomized; 12 Mos Treatment) | 6 | 153 | 6 |
| other | Diarrhoea | Gastrointestinal disorders | CTAP101 Caps 2 x 30 mcg Daily for 12 wk+Adjunctive | 1 | 42 | 1 |
| other | Nausea | Gastrointestinal disorders | CTAP101 Capsules (Not Randomized; 6 Mos Treatment) | 8 | 103 | 8 |
| other | Nausea | Gastrointestinal disorders | CTAP101 Capsules (Not Randomized; 12 Mos Treatment) | 5 | 153 | 5 |
| other | Nausea | Gastrointestinal disorders | CTAP101 Caps 2 x 30 mcg Daily for 12 wk+Adjunctive | 2 | 42 | 2 |
| other | Oedema peripheral | General disorders | CTAP101 Capsules (Not Randomized; 6 Mos Treatment) | 6 | 103 | 6 |
| other | Oedema peripheral | General disorders | CTAP101 Capsules (Not Randomized; 12 Mos Treatment) | 5 | 153 | 5 |
| other | Oedema peripheral | General disorders | CTAP101 Caps 2 x 30 mcg Daily for 12 wk+Adjunctive | 0 | 42 | 0 |
| other | Fatigue | General disorders | CTAP101 Capsules (Not Randomized; 6 Mos Treatment) | 7 | 103 | 7 |
| other | Fatigue | General disorders | CTAP101 Capsules (Not Randomized; 12 Mos Treatment) | 3 | 153 | 3 |
| other | Fatigue | General disorders | CTAP101 Caps 2 x 30 mcg Daily for 12 wk+Adjunctive | 1 | 42 | 1 |
| other | Urinary tract obstruction | Infections and infestations | CTAP101 Capsules (Not Randomized; 6 Mos Treatment) | 2 | 103 | 2 |
| other | Urinary tract obstruction | Infections and infestations | CTAP101 Capsules (Not Randomized; 12 Mos Treatment) | 10 | 153 | 10 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02282813/events